(Q37845201)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

review article

1 reference

title

Bevacizumab as a treatment option for radiation-induced cerebral necrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Christiane Matuschek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Edwin Bölke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Jens Nawatny

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Thomas K Hoffmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Matthias Peiper

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Klaus Orth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Ethelyn Rusnak

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Guido Lammering

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Wilfried Budach

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

24 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

Strahlentherapie und Onkologie

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

135-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

Clinical and radiobiological advantages of single-dose stereotactic light-ion radiation therapy for large intracranial arteriovenous malformations. Technical note

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Effect of bevacizumab on radiation necrosis of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Hypofractionated reirradiation for recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Comparison of stereotactic radiosurgery and fractionated stereotactic radiotherapy of acoustic neurinomas according to 3-D tumor volume shrinkage and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Technical considerations for noncoplanar proton-beam therapy of patients with tumors proximal to the optic nerve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Reirradiation of multiple brain metastases with helical tomotherapy. A multifocal simultaneous integrated boost for eight or more lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Upregulation of vascular endothelial growth factor is associated with radiation-induced blood-spinal cord barrier breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Inhibition of vascular endothelial growth factor signalling using cediranib (RECENTIN; AZD2171) enhances radiation response and causes substantial physiological changes in lung tumour xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Radiation-induced astrogliosis and blood-brain barrier damage can be abrogated using anti-TNF treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Bevacizumab reverses cerebral radiation necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2184-4

Modification of WR-2721 radiation protection from gastrointestinal injury and death in mice by 2-mercaptopropionylglycine

21 January 2018

1 reference

12 December 2020

[Radiotherapy and radiosurgery of pituitary adenomas]

1 reference

12 December 2020

Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system

1 reference

12 December 2020

[Radiation necrosis after stereotactic radiosurgery for benign glioma]

1 reference

12 December 2020

The risk of cerebral radionecrosis in relation to dose, time and fractionation. A follow-up study

1 reference

12 December 2020

The effect of human cord blood therapy on the intestinal tract of lethally irradiated mice: possible use for mass casualties

1 reference

12 December 2020

10.1007/S00066-010-2184-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336713%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference